Screener
Artiva Biotherapeutics, Inc. ARTV Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
| Line item | THREE MONTHS ENDED JUNE 30, 2026 | THREE MONTHS ENDED JUNE 30, 2025 | SIX MONTHS ENDED JUNE 30, 2026 | SIX MONTHS ENDED JUNE 30, 2025 |
|---|---|---|---|---|
| Net loss | $(25,005) | $(21,254) | $(48,521) | $(41,565) |
| Net loss per share, basic and diluted | $(0.63) | $(0.87) | $(1.51) | $(1.71) |
| Weighted-average common shares outstanding, basic and diluted | 39,413,236 | 24,378,823 | 32,086,532 | 24,360,502 |
| Comprehensive loss: | ||||
| Net loss | $(25,005) | $(21,254) | $(48,521) | $(41,565) |
| Other comprehensive (loss) income: | ||||
| Unrealized (loss) gain on investments, net | (3) | 2 | (124) | 131 |
| Comprehensive loss | $(25,008) | $(21,252) | $(48,645) | $(41,434) |
Item 1. Financial Statements
FAQ
- What is Artiva Biotherapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Artiva Biotherapeutics, Inc. (ARTV) reported comprehensive income (loss), net of tax, attributable to parent of -$25.01M in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Artiva Biotherapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 17.7% year-over-year, from -$21.25M to -$25.01M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 71.6% compound annual growth rate (CAGR), from -$28.41M to -$83.63M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items like foreign currency adjustments or unrealized gains on securities. It offers a more holistic view of the company's financial performance and changes in net worth than net income alone. Investors use this to assess the total impact of all financial activities on the company's overall economic position.
Ask your AI about Artiva Biotherapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude